1-7 of 7
James Butler
Close
Sort by
Journal Articles

Classical Hematology Referrals at an NCI-Designated Cancer Center: Lessons Learned

Chase West, Matthew James Butler, Supreet Kaur, Anand Karnad
Journal: Blood
Blood (2022) 140 (Supplement 1): 5025–5026.
https://doi.org/10.1182/blood-2022-158377
Published: 2022
Journal Articles

Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Adolfo Enrique Diaz Duque, Anand Karnad, Matthew James Butler, Elizabeth Bowhay-Carnes, Joel E Michalek, Gabriela Huelgas, Ricardo Aguiar
Journal: Blood
Blood (2022) 140 (Supplement 1): 6610–6611.
https://doi.org/10.1182/blood-2022-167001
Published: 2022
Journal Articles

Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Adolfo E Diaz, MD, Matthew James Butler, MD, Anand Karnad, MD, Ricardo Aguiar, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1592.
https://doi.org/10.1182/blood-2019-124382
Published: 2019
Journal Articles

Prognostic Factors and Survival Outcomes in Phase I Patients with Hematologic Malignancies

Matthew James Butler, MD, Josephine A Taverna, MD, Zuxi Cui, MS, Jiao Yu, MA, Joel E Michalek, PhD, Alex Bokov, PhD, Laura S Manuel, Amelie G Ramirez, DrPH, Alex V. Mejia, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3452.
https://doi.org/10.1182/blood.V130.Suppl_1.3452.3452
Published: 2017
Journal Articles

Development Of RNAi Therapeutics Targeting The Complement Pathway

Anna Borodovsky, PhD, Kristina Yucius, Andrew Sprague, James Butler, PhD, Shannon Fishman, BS, Tuyen Nguyen, Akshay Vaishnaw, MD, PhD, Martin Maier, PhD, Rajeev Kallanthottathil, PhD, Satya Kuchimanchi, PhD, Muthiah Manoharan, PhD, Rachel Meyers, PhD, Kevin Fitzgerald, PhD
Journal: Blood
Blood (2013) 122 (21): 2471.
https://doi.org/10.1182/blood.V122.21.2471.2471
Published: 2013
Journal Articles

Aln-TMP: A Subcutaneously Administered RNAi Therapeutic Targeting Tmprss6 For The Treatment Of β-Thalassemia

James Butler, PhD, Shannon Fishman, BS, Tim Racie, BS, Julia Hettinger, BS, Brian R Bettencourt, PhD, Klaus Charisse, PhD, Kevin Fitzgerald, PhD
Journal: Blood
Blood (2013) 122 (21): 2260.
https://doi.org/10.1182/blood.V122.21.2260.2260
Published: 2013
Journal Articles

Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia

Kitty de Jong, Renee K. Emerson, James Butler, Jacob Bastacky, Narla Mohandas, Frans A. Kuypers
Journal: Blood
Blood (2001) 98 (5): 1577–1584.
https://doi.org/10.1182/blood.V98.5.1577
Published: 2001